FDA Advisory Panel Recommends Approval Of GSK’s, Pfizer’s RSV Vaccines For Older Adults

The New York Times (3/1, Jewett) reports an FDA “advisory panel on Wednesday recommended approval of a second vaccine for the respiratory syncytial virus in older adults.” Over a two-day period, “the panel debated and then voted in favor of two vaccines,...